Investigational Site Number : 7240002

Vigo 36312

0 studies enrolling now · 2 studies all time

What they study most

Chronic Kidney Diseases, Heart Failure, Multiple Sclerosis, Type 2 Diabetes Mellitus

Studies at this site

• Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis — Running, not enrolling
• Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk — Stopped early